Publish, not perish: Introducing Experimental Hematology & Oncology

Area of Science:

• Medicine
• Biomedical Research
• Scientific Publishing

Background:

• Advancement in medicine relies on rigorous experimentation to validate or refute hypotheses.
• Current publication trends heavily favor positive research findings, particularly in clinical trials.
• This bias can hinder the dissemination of valuable negative or inconclusive experimental data.

Purpose of the Study:

• Introduce Experimental Hematology & Oncology (eHO) as a new open access journal.
• Highlight eHO's commitment to publishing negative clinical trial results and provocative basic science studies.
• Emphasize eHO's focus on technical merit and rapid information dissemination over extensive post-peer review experiments.

Main Methods:

• Establishing a new open access online journal, Experimental Hematology & Oncology (eHO).
• Implementing a peer-review process that prioritizes technical merit.
• Actively soliciting and publishing preclinical, patient-oriented, and translational research, including negative findings.

Main Results:

• eHO provides a dedicated platform for research that might not be favored by traditional publication venues.
• The journal aims to accelerate scientific progress by publishing a broader spectrum of experimental outcomes.
• Focusing on technical merit ensures the quality and reliability of published research.

Conclusions:

• Experimental Hematology & Oncology (eHO) addresses a critical gap in scientific publishing by embracing negative and provocative results.
• The journal's approach facilitates faster and more comprehensive knowledge sharing in medicine and oncology.
• eHO promotes a more balanced and efficient advancement of biomedical science through open access and streamlined peer review.